SEI Investments’s Ironwood Pharmaceuticals IRWD Stock Holding History

SEI Investments’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.61M	Buy	742,548 +68,686	+10%	+$282K	﹤0.01%	1875
2025 Q4	$2.27M	Sell	673,862 -9,742	-1%	-$25.3K	﹤0.01%	1780
2025 Q3	$896K	Hold	683,604	–	–	﹤0.01%	2007
2025 Q2	$490K	Buy	683,604 +496,857	+266%	+$390K	﹤0.01%	2195
2025 Q1	$275K	Buy	186,747 +44,832	+32%	+$107K	﹤0.01%	2368
2024 Q4	$629K	Sell	141,915 -268,765	-65%	-$1.09M	﹤0.01%	2105
2024 Q3	$1.69M	Buy	+410,680	New	+$2.21M	﹤0.01%	1762
2024 Q1	–	Sell	-190,143	Closed	-$2.18M	–	2668
2023 Q4	$2.18M	Buy	190,143 +144	+0.1%	+$1.42K	﹤0.01%	1565
2023 Q3	$1.83M	Buy	189,999 +22,143	+13%	+$217K	﹤0.01%	1638
2023 Q2	$1.79M	Sell	167,856 -11,462	-6%	-$123K	﹤0.01%	1679
2023 Q1	$1.89M	Buy	179,318 +9,082	+5%	+$102K	﹤0.01%	1647
2022 Q4	$2.11M	Buy	170,236 +17,918	+12%	+$203K	﹤0.01%	1474
2022 Q3	$1.58M	Buy	152,318 +122,992	+419%	+$1.39M	﹤0.01%	1641
2022 Q2	$384K	Buy	29,326 +323	+1%	+$3.81K	﹤0.01%	2213
2022 Q1	$404K	Buy	29,003 +529	+2%	+$6.06K	﹤0.01%	2181
2021 Q4	$375K	Sell	28,474 -102,533	-78%	-$1.26M	﹤0.01%	2256
2021 Q3	$1.74M	Buy	131,007 +98,150	+299%	+$1.27M	﹤0.01%	1560
2021 Q2	$440K	Buy	+32,857	New	+$376K	﹤0.01%	2164
2021 Q1	–	Sell	-230,146	Closed	-$2.59M	–	2505
2020 Q4	$2.59M	Buy	230,146 +9,306	+4%	+$102K	0.01%	1266
2020 Q3	$1.95M	Buy	220,840 +112,015	+103%	+$1.11M	0.01%	1294
2020 Q2	$1.11M	Buy	108,825 +24,036	+28%	+$246K	﹤0.01%	1519
2020 Q1	$855K	Sell	84,789 -2,570	-3%	-$30.2K	﹤0.01%	1522
2019 Q4	$1.16M	Buy	87,359 +24,728	+39%	+$273K	﹤0.01%	1586
2019 Q3	$538K	Buy	62,631 +857	+1%	+$8.33K	﹤0.01%	1853
2019 Q2	$676K	Buy	+61,774	New	+$692K	﹤0.01%	1737
2018 Q3	–	Sell	-3,769	Closed	-$60K	–	2960
2018 Q2	$60K	Buy	3,769 +56	+2%	+$829	﹤0.01%	2450
2018 Q1	$48K	Sell	3,713 -288,854	-99%	-$3.6M	﹤0.01%	2366
2017 Q4	$3.67M	Sell	292,567 -8,725	-3%	-$114K	0.01%	1043
2017 Q3	$3.98M	Buy	301,292 +34,045	+13%	+$468K	0.01%	983
2017 Q2	$4.23M	Buy	267,247 +26,983	+11%	+$392K	0.02%	909
2017 Q1	$3.43M	Buy	240,264 +38,946	+19%	+$532K	0.02%	949
2016 Q4	$2.58M	Buy	201,318 +201,245	+275,678%	+$2.54M	0.01%	1057
2016 Q3	$1K	Hold	73	–	–	﹤0.01%	2737
2016 Q2	$1K	Hold	73	–	–	﹤0.01%	2550
2016 Q1	$1K	Buy	+73	New	+$602	﹤0.01%	2434
2015 Q4	–	Sell	-62,997	Closed	-$550K	–	2605
2015 Q3	$550K	Buy	+62,997	New	+$588K	0.01%	1253

Other funds holding IRWD

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SEI Investments's IRWD Position: Q1 2026 in Review

SEI Investments increased its Ironwood Pharmaceuticals (IRWD) stake by 10% in Q1 2026, buying an estimated $282K and bringing the position to 742,548 shares worth $2.61M. The position accounts for ﹤0.01% of the portfolio, ranked #1875.

SEI Investments first reported a position in IRWD in Q3 2015 and has held it in 36 quarters since. The position peaked at $4.23M in Q2 2017. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

SEI Investments held 742,548 shares of Ironwood Pharmaceuticals worth $2.61M as of Q1 2026.
SEI Investments bought 68,686 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $282K.
Ironwood Pharmaceuticals made up ﹤0.01% of SEI Investments's portfolio in Q1 2026, its #1875 holding.
SEI Investments first reported a position in Ironwood Pharmaceuticals in Q3 2015 and has held it in 36 quarters since.
SEI Investments's Ironwood Pharmaceuticals position peaked at $4.23M in Q2 2017.
226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.